ライフサイエンスコーパス: pelvic pain

1 ctomy (PN) for chronic endometriosis-related pelvic pain.

2 rate to severe dysmenorrhea and non-cyclical pelvic pain.

3 inary urgency; and 2.2 (95% CI, 1.2-3.9) for pelvic pain.

4 ymptoms include reduced fertility and severe pelvic pain.

5 oing laparotomy, 20 of whom reported chronic pelvic pain.

6 n young, nulliparous women with abdominal or pelvic pain.

7 0 years), uterine nerve ablation for chronic pelvic pain.

8 ening dysmenorrhea, dyspareunia, and overall pelvic pain.

9 orientation and management of patients with pelvic pain.

10 of the urinary bladder and persistent aching pelvic pain.

11 y associated with severe, acute, and chronic pelvic pain.

12 th intermenstrual bleeding, dyspareunia, and pelvic pain.

13 oman presented with increasing abdominal and pelvic pain.

14 ndent condition that causes dysmenorrhea and pelvic pain.

15 as therapeutic targets for treating chronic pelvic pain.

16 one-year history of dysmenorrhea and cyclic pelvic pain.

17 have an adnexal mass with acute or subacute pelvic pain.

18 % of women and is associated with persistent pelvic pain.

19 and (3) an operation to address the groin or pelvic pain.

20 eeding, primary amenorrhea, pelvic mass, and pelvic pain.

21 s mutation led to his chronic infections and pelvic pain.

22 diated adaptive immune mechanisms in chronic pelvic pain.

23 i isolate (CP-1) from a patient with chronic pelvic pain.

24 t important for the care of men with chronic pelvic pain.

25 ed NOD mice was sufficient to induce chronic pelvic pain.

26 onic fungal rash of the scrotum, and chronic pelvic pain.

27 n and erosion and increased dyspareunia, and pelvic pain.

28 infertility, ectopic pregnancy, and chronic pelvic pain.

29 a treatment option for patients with chronic pelvic pain.

30 visibility (26.1%; 95% CI, 10.2%-48.4%) and pelvic pain (14.5%; 95% CI, 7.7%-23.9%).

31 s review of surgical patients with groin and pelvic pain, 2008-2013, was conducted in a single-surgeo

32 common clinical diagnoses were abdominal and pelvic pain (47 patients [20.4%]), iron deficiency (43 p

33 broids (1167 [78.1%]), vaginal bleeding, and pelvic pain (857 [57.4%]) were the most common presentin

34 Chronic pelvic pain accounts for 40% of laparoscopies and 12% of

35 Endometriosis is a common cause of pelvic pain affecting approximately 10% of reproductive-

36 Chronic pelvic pain affects 2-24% of women worldwide and evidenc

37 Children usually have progressive pelvic pain after menarche, palpable mass due to hemihae

38 ctomy for endometriosis experience recurrent pelvic pain and 10% undergo additional surgery, such as

39 (26 of 31 patients) in the context of acute pelvic pain and 92.6% (25 of 27 patients), 88.9% (24 of

40 the uterus, is the leading cause of chronic pelvic pain and infertility in females of reproductive a

41 common gynecological disease, causes chronic pelvic pain and infertility in women of reproductive age

42 Endometriosis is a common cause of pelvic pain and infertility in women, and a common indic

43 ommon chronic inflammatory condition causing pelvic pain and infertility in women, with limited treat

44 Endometriosis is a common cause of pelvic pain and infertility, affecting approximately 10%

45 n of reproductive age and is associated with pelvic pain and infertility, and its pathogenesis is not

46 Patients experience chronic pelvic pain and infertility, with the most likely origin

47 fects 10-15% of women and is associated with pelvic pain and infertility.

48 of symptoms and severity, including chronic pelvic pain and infertility.

49 -like tissue grows ectopically, resulting in pelvic pain and infertility.

50 ommon condition associated with debilitating pelvic pain and infertility.

51 ommon gynaecological disease associated with pelvic pain and infertility.

52 nt leads to complications, including chronic pelvic pain and infertility.

53 d safety of gabapentin in women with chronic pelvic pain and no obvious pelvic pathology.

54 bel gabapentin for the management of chronic pelvic pain and no obvious pelvic pathology.

55 The majority of patients with pelvic pain and normal pelvic US findings had improvemen

56 Data from 86 female patients with pelvic pain and normal pelvic US findings seen in a US s

57 ing their reproductive age, causing years of pelvic pain and potential infertility.

58 necological disorder, associated with severe pelvic pain and reduced fertility; however, its molecula

59 There is a mixed impact on pelvic pain and sexual function which requires careful c

60 There is a mixed impact on pelvic pain and sexual function which requires careful c

61 oms of endometriosis are chronic intolerable pelvic pain and subfertility or infertility, which profo

62 lammatory condition in women that results in pelvic pain and subfertility, and has been associated wi

63 characterized by histologic endometritis or pelvic pain and tenderness plus one of the following: or

64 defined as 1) histologic endometritis or 2) pelvic pain and tenderness plus oral temperature >38.8 d

65 ladder pain syndrome, a clinical syndrome of pelvic pain and urinary urgency/frequency in the absence

66 logue scales (VAS) for dysmenorrhea, chronic pelvic pain, and deep dyspareunia and answered questions

67 c pain, including dysmenorrhea, nonmenstrual pelvic pain, and dyspareunia, and 26% report infertility

68 gic disorder characterized by bladder and/or pelvic pain, and excessive urinary frequency and/or urge

69 important causes of intestinal obstruction, pelvic pain, and female infertility.

70 syndromes irritable bowel syndrome, chronic pelvic pain, and fibromyalgia were assessed by questionn

71 ing cause of intestinal obstruction, chronic pelvic pain, and infertility in women.

72 frequent cause of abnormal uterine bleeding, pelvic pain, and infertility.

73 ould alleviate pain, including non-menstrual pelvic pain, and modify the underlying disease pathophys

74 ing is warranted in patients presenting with pelvic pain, and more aggressive pain management strateg

75 g-term outcomes such as dyspareunia, chronic pelvic pain, and vaginal distortion, which may occur eve

76 ntly lower pain scores in women with chronic pelvic pain, and was associated with higher rates of sid

77 of the patients after LVMR but new onset of pelvic pain appeared in 15%.

78 Subfertility and severe pelvic pains are symptoms associated with endometriosis

79 mechanisms underlying chronic abdominal and pelvic pain associated with functional and inflammatory

80 inical response with respect to nonmenstrual pelvic pain at 3 months.

81 The primary outcome was chronic pelvic pain at follow-up measured on a scale of 0 to 10,

82 ne per cent of all women suffer from chronic pelvic pain at some point in their lives, and pelvic ven

83 areunia, abnormal vaginal discharge, chronic pelvic pain, avoiding sexual intercourse, odor associate

84 approach in diagnosing and treating chronic pelvic pain, because it is common knowledge that differe

85 A murine UTI model was used to compare pelvic pain behavior elicited by infection with uropatho

86 CP1 induced pelvic pain behavior exclusively in NOD mice and not in

87 week 24 for dysmenorrhoea and non-menstrual pelvic pain, both based on NRS scores and analgesic use.

88 ion of abdominal or pelvic injury that cause pelvic pain, bowel obstruction, and infertility in women

89 our patients presented with abdominal and/or pelvic pain, but only one of these four had cyclic pain

90 Chronic pelvic pain conditions often overlap with nonpelvic pain

91 Chronic pelvic pain (CPP) affects a significant number of women

92 me, interstitial cystitis, and other chronic pelvic pain (CPP) disorders often occur concomitantly.

93 The diagnosis and treatment of chronic pelvic pain (CPP) have moved away from targeting a speci

94 Chronic pelvic pain (CPP) is a challenging condition that affect

95 adolescents with dysmenorrhea and/or chronic pelvic pain (CPP) who are suspected to have endometriosi

96 These species, deficient in IC pelvic pain (DIPP), were further evaluated by Receiver-o

97 vis may contribute to etiology of functional pelvic pain disorders such as interstitial cystitis/blad

98 e in improving dysmenorrhea and nonmenstrual pelvic pain during a 6-month period in women with endome

99 such as pelvic inflammatory disease, chronic pelvic pain, ectopic pregnancy and epididymitis.

100 Pelvic pain, either related or unrelated to menstruation

101 with surgically confirmed endometriosis and pelvic pain enrolled in a double-blind, randomized, plac

102 s assessed in seven women who presented with pelvic pain, fever, and presumed pelvic abscess.

103 isciplinary Approach to the Study of Chronic Pelvic Pain findings and external research, empirically

104 2 of 27 patients) in the context of subacute pelvic pain for readers 1, 2, and 3, respectively.

105 However, women with infertility and chronic pelvic pain have an even greater prevalence, accounting

106 with vitamin D led to significant changes in pelvic pain; however, these were similar in magnitude to

107 Pelvic pain improved or resolved in 66 (77%) of the 86 p

108 d at a tertiary center for endometriosis and pelvic pain in British Columbia, Canada, included all pa

109 es, suggesting that the microbiome modulates pelvic pain in IC.

110 7A-expressing cells was sufficient to induce pelvic pain in naive NOD recipients.

111 howed that CP1 induced and sustained chronic pelvic pain in NOD mice, an attribute not exhibited by a

112 We developed an infection model of chronic pelvic pain in NOD/ShiLtJ (NOD) mice with a clinical Esc

113 include it in the differential diagnosis of pelvic pain in women of child-bearing age.

114 ummarize new findings in the area of chronic pelvic pain in women of childbearing age.

115 Pelvic pain in women with endometriosis is attributed to

116 Endometriosis is a common cause of pelvic pain in women, for which current treatment option

117 isorder that is associated with debilitating pelvic pain in women.

118 ver, 90% of people with endometriosis report pelvic pain, including dysmenorrhea, nonmenstrual pelvic

119 Disease associated pelvic pain; infertility and sexual dysfunction have a s

120 Chronic pelvic pain is a common condition with a major effect on

121 Pelvic pain is a major component of the morbidity associ

122 Chronic pelvic pain is like other chronic pain syndromes in that

123 Severe pelvic pain is often associated with endometriosis, and

124 A classification of chronic pelvic pain is presented, along with the recommended eva

125 e of dorsal root ganglia neurons to decrease pelvic pain; (iv) decreases proinflammatory, estrogen-do

126 d controlled trial of 487 women with chronic pelvic pain lasting longer than 6 months without or with

127 Among women with chronic pelvic pain, LUNA did not result in improvements in pain

128 isciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network uses a novel integra

129 isciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

130 isciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

131 The 1 World Congress on Pelvic Pain met in 2013 to further collaborate on diagno

132 n result in substantial morbidity, including pelvic pain, multiple operations, and infertility.

133 on two or more days and a mean non-menstrual pelvic pain NRS score of 2.5 or higher, or a mean score

134 significantly associated with higher chronic pelvic pain (odds ratio [OR], 1.02; 95% CI, 1.00-1.03; P

135 plays a central role in the pathogenesis of pelvic pain, one of the core symptoms of endometriosis.

136 c pelvic pain syndrome (CP/CPPS) presents as pelvic pain or discomfort for at least 3 months and is a

137 g modality used when patients report chronic pelvic pain or have issues of infertility, both common s

138 ith irregular or excessive uterine bleeding, pelvic pain or pressure, or infertility.

139 tension-type headache was 4% (2-9); chronic pelvic pain or prostatitis was 11% (8-17); and fibromyal

140 .12-4.69, I(2) = 0%; 3 studies), and chronic pelvic pain (OR, 2.73; 95% CI, 1.73-4.30, I(2) = 40%; 10

141 algia (OR, 3.35; 95% CI, 1.51-7.46), chronic pelvic pain (OR, 3.27; 95% CI, 1.02-10.53), and function

142 pelvis where it causes inflammation, chronic pelvic pain, pain with intercourse and menses, and infer

143 rcourse presented with complaints of intense pelvic pain radiating to the perineal area.

144 is a common cause of both cyclic and chronic pelvic pain, reduced fertility, and reduced quality-of-l

145 isciplinary Approach to the Study of Chronic Pelvic Pain Research Network has identified important ph

146 bination therapy group met the non-menstrual pelvic pain responder criteria versus 84 (40%) patients

147 136 (66%) of 206 patients were non-menstrual pelvic pain responders in the relugolix combination ther

148 It can exhibit acute pelvic pain shortly after menarche and may show non-spec

149 Other' taxa) than symptomatic controls (with pelvic pain, surgically confirmed absence of endometrios

150 In contrast, chronic prostatitis/chronic pelvic pain syndrome (category III), which accounts for

151 isorders(MHD) in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) have been widely studied.

152 Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) in men is principally def

153 Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a debilitating syndrom

154 Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) presents as pelvic pain o

155 Prostatitis [chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)] is a common condition in

156 and treatment of chronic prostatitis/chronic pelvic pain syndrome (CPPS).

157 Urologic chronic pelvic pain syndrome (UCPPS), which encompasses intersti

158 categorize male chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/bladder p

159 zation, and treatment of prostatitis/chronic pelvic pain syndrome based on the National Institutes of

160 The etiology of chronic prostatitis/chronic pelvic pain syndrome in men is unknown but may involve m

161 Treatment of chronic prostatitis/chronic pelvic pain syndrome is often empirical because clinical

162 The aetiology of chronic pelvic pain syndrome is still not certain, although an a

163 In chronic pelvic pain syndrome, a recent placebo-controlled trial

164 ain syndrome and chronic prostatitis/chronic pelvic pain syndrome, collectively referred to as urolog

165 nditions such as chronic prostatitis/chronic pelvic pain syndrome, interstitial cystitis/bladder pain

166 ain syndrome and chronic prostatitis/chronic pelvic pain syndrome, is characterized by chronic pain i

167 ated bacteria to chronic prostatitis/chronic pelvic pain syndrome.

168 ndomized clinical trials in urologic chronic pelvic pain syndrome.

169 collectively referred to as urologic chronic pelvic pain syndrome.

170 arget to control chronic prostatitis/chronic pelvic pain syndrome.

171 he human disease chronic prostatitis/chronic pelvic pain syndrome.

172 thus serve as initiating agents for chronic pelvic pain through mechanisms that are dependent on bot

173 Use of the descriptive diagnosis 'pelvic pain', traditionally limited to gynecological pai

174 e complications cause lifelong, irreversible pelvic pain, vaginal shortening, vaginal narrowing, seve

175 inical response with respect to nonmenstrual pelvic pain was 50.4% in the lower-dose elagolix group a

176 Chronic pelvic pain was also associated with both depression (OR

177 Pelvic pain was not abolished in NOD-IFN-gamma-KO mice b

178 Pelvic pain was reported to be improved in 47% of the pa

179 Using behavioral measures of pelvic pain, we showed that CP1 induced and sustained ch

180 aroscopic uterine nerve ablation for chronic pelvic pain were measured.

181 ith respect to dysmenorrhea and nonmenstrual pelvic pain were sustained at 6 months.

182 NU14-infected mice exhibited pelvic pain, whereas mice infected with 83972 did not ex

183 All patients with acute or subacute pelvic pain who were undergoing MR examination for the e

184 ligible participants were women with chronic pelvic pain (with or without dysmenorrhoea or dyspareuni

185 ications and 25% to 34% experience recurrent pelvic pain within 12 months of discontinuing hormonal t